A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia

Exclusion Criteria

• •1. Previous failure or recurrence of radiofrequency ablation
• •2. Left ventricular ejection fraction (LVEF) ≤ 40%
• •3. Combined with atrial flutter or atrial fibrillation
• •4. Combination of thromboembolic disease
• •5. Women who are breastfeeding, pregnant or planning to become pregnant during the study period
• •6. Carrying active implants in the body (e.g., pacemakers, ICDs, etc.)
• •7. Patients with second-degree (type II) or third-degree atrioventricular block
• •8. NYHA Class III-IV cardiac function \[Appendix 1\]
• •9. Patients with congenital heart disease (excluding atrial septal defect and patent foramen ovale)
• •10. Patients with definite acute cerebrovascular disease (including cerebral hemorrhage, stroke, transient ischemic attack) within the last 1 month
• •11. cardiovascular events within the last 3 months (including acute myocardial infarction, coronary intervention or heart bypass surgery, prosthetic valve replacement or repair, atrial or ventriculotomy)
• •12. Acute or severe systemic infection
• •13. Patients with severe liver and kidney diseases, malignant tumors and end-stage diseases
• •14. Patients with significant bleeding tendency, hypercoagulable state and serious hematologic disorders
• •15. Patients who have participated or are participating in other clinical trials within 3 months before enrollment
• •16. Patients who have other conditions that the investigator considers inappropriate for participation in this trial.